In today’s episode, I bring you Part 2 of an interview with Naganand Doraswamy, managing partner, and Suryaprakash Konanuru, CTO, at Ideaspring Capital in Bengaluru.
In this episode, we pick up the conversation with a brief discussion on what the two VC investors are seeing when it comes to the growth of translational research in India — and I want to add that this was in the broader sense of any movement from scientific lab to commercial product, and not just in the medical field, where the term originated.
And if you stick around you’ll hear Naganand and Suri discuss their views on how early-stage investing in deep tech is changing, can such investors make meaningful investments in highly capital intensive sectors such as robotics, nuclear fusion and quantum computing hardware, in India, getting something not quite right but moving on, and whether AI is changing their work as well, and in what ways.
And as promised in Part 1, we take a quick look at what might represent a ‘Flipkart moment’ in India’s deep tech sector, and the evolution of Ideaspring itself from Fund 1 to Fund 4.
